Intelligent Neurological Function Evaluation System

An integrated system that combines AI, IoT, blockchain, and new materials to evaluate and improve neurological and cognitive function, enhancing patient outcomes and experiences.

The original patent addressed the need for a performance test to evaluate neurological function. However, it lacked the capacity to integrate with emerging technologies, limiting its potential. The new inventive concept solves this problem by synergistically combining the original apparatus with AI, IoT, blockchain, and new materials to create a more comprehensive and powerful system.

The system comprises an apparatus integrated with an AI-powered analytics module, which provides real-time assessment of neurological and cognitive function. The apparatus is further connected to an IoT-based sensor network, collecting and analyzing environmental and physiological data. A blockchain-based data storage system securely stores and manages patient data. The system also features a moveable platform with an integrated AI-powered chatbot, assisting patients during testing, and a new material-based contact surface enhancing the user experience. Additionally, the system includes a machine learning-based predictive model to identify potential neurological disorders and a blockchain-based rewards platform to incentivize patients to undergo regular testing.

The new claims introduce the integration of AI, IoT, blockchain, and new materials with the original apparatus, creating a synergistic system that provides real-time assessment, personalized reports, and enhanced user experience. This integration is novel and non-obvious compared to the original patent.

Alternative embodiments could include integrating the system with virtual or augmented reality platforms, using different types of sensors or data analytics modules, or incorporating additional AI-powered features such as personalized coaching or predictive modeling. Variations could also include adapting the system for use in different settings, such as clinics, hospitals, or remote monitoring environments.

The Intelligent Neurological Function Evaluation System has significant commercial potential in the healthcare and medical technology industries, particularly in the areas of neurological disorder diagnosis, treatment, and management. The system could be marketed to hospitals, clinics, and research institutions, with potential for expansion into remote patient monitoring and personalized health services.